1-244451769-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001126.5(ADSS2):c.49G>A(p.Asp17Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,599,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001126.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADSS2 | NM_001126.5 | c.49G>A | p.Asp17Asn | missense_variant | 1/13 | ENST00000366535.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADSS2 | ENST00000366535.4 | c.49G>A | p.Asp17Asn | missense_variant | 1/13 | 1 | NM_001126.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152004Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 7AN: 219596Hom.: 0 AF XY: 0.0000418 AC XY: 5AN XY: 119564
GnomAD4 exome AF: 0.000118 AC: 171AN: 1447932Hom.: 0 Cov.: 31 AF XY: 0.000114 AC XY: 82AN XY: 719216
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152004Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74208
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2022 | The c.49G>A (p.D17N) alteration is located in exon 1 (coding exon 1) of the ADSS gene. This alteration results from a G to A substitution at nucleotide position 49, causing the aspartic acid (D) at amino acid position 17 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at